$0.00
(0.00%
) Quote details
USD
$0.00
(0.00%
)At Close (As of Dec 9, 2025)
$293.59M
Market Cap
-
P/E Ratio
-4.2
EPS
$20.90
52 Week High
$7.00
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - GENERAL
Amarin Corporation PLC is a Dublin-based biopharmaceutical company focused on developing and commercializing innovative therapies for cardiovascular diseases, with a primary emphasis on the U.S. market. Its flagship product, Vascepa, is a prescription medication recognized for its efficacy in significantly lowering triglyceride levels among patients with elevated cardiovascular risk. The company is committed to advancing its research pipeline, exploring new clinical applications for Vascepa, and expanding market access to strengthen its foothold within the cardiovascular health sector. With a strategic focus on innovation and patient outcomes, Amarin is poised to remain a significant contributor to advancements in cardiovascular therapeutics.
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
SLM
NVTS
AGNC
NCLH
HOOD
PCG
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
SLM
NVTS
AGNC
NCLH
HOOD
PCG